Introduction
============

Sleep disturbance is common among intensive care unit (ICU) patients and has a negative impact on a variety of outcomes.[@b1-ijgm-12-125]--[@b3-ijgm-12-125] More than half of ICU survivors report having insomnia, nightmares, and poor-quality sleep. These symptoms can persist for as long as 12 months after hospital discharge and decrease quality of life.[@b4-ijgm-12-125],[@b5-ijgm-12-125] Sleep is crucial for rest, recovery, and well-being.[@b6-ijgm-12-125],[@b7-ijgm-12-125] A wide spectrum of potential risk factors for post-ICU sleep disturbances have been identified, including hypnotic drug use, illness severity, female gender, older age, respiratory failure, and others.[@b4-ijgm-12-125] Previous studies have shown an association between psychiatric symptoms and post-ICU sleep disturbances.[@b8-ijgm-12-125]--[@b13-ijgm-12-125] Sleep deprivation has been linked to delirium, cardiovascular, immune and endocrine dysfunction, cognitive impairment, and even mortality,[@b14-ijgm-12-125]--[@b18-ijgm-12-125] making identification of risk factors important. The aim of this study was to gain further insight into the relationship between psychiatric symptoms and sleep disturbances in ICU survivors.

We hypothesized that psychiatric symptoms would be associated with post-ICU sleep disturbances in patients recruited from the Critical Care Recovery Center (CCRC) at Eskenazi Hospital in Indianapolis, IN, USA.

Study population
----------------

Two hundred and thirty-three ICU survivors were seen in the CCRC, an ICU survivor clinic, from July 2011 to August 2016. Patients were excluded if they did not complete questions about sleep changes (N=49), trauma (N=43), or depression (N=29). The final sample included 112 patients. Referral criteria to the CCRC were age 18 years or older, admitted to the ICU, on mechanical ventilation or delirious for ≥48 hours (major risk factors for the development of post-intensive care syndrome),[@b19-ijgm-12-125],[@b20-ijgm-12-125] and recommended for follow-up by a critical care physician. Exclusion criteria included enrollment into hospice or palliative care services. Indiana University Institutional Review Board (IRB) approval was obtained to conduct retrospective analyses of de-identified clinical data. Medical history and medication lists were collected from patients, informal caregivers, and electronic medical records. Patient consent to review their medical data was not required by the IRB due to anonymization, and the study complied with the Declaration of Helsinki.

Data collection
---------------

Electronic medical records were reviewed to determine whether patients were on an antidepressant, a benzodiazepine, or nonbenzodiazepine hypnotic (zolpidem, zopiclone, eszopiclone, or zaleplon) at their initial CCRC visit ([Table 1](#t1-ijgm-12-125){ref-type="table"}).

Sleep disturbances
------------------

Patients indicated whether they had any of the following current sleep disturbances (they could mark more than one) as part of an initial CCRC patient assessment 3 months after ICU discharge: insomnia (subjective loss of sleep, nearly every day for two weeks); hard time falling asleep; hypersomnia (subjective excess sleep, nearly every day for two weeks); hard time staying asleep; excessive day time sleepiness (nearly every day for two weeks); and not feeling refreshed in the morning.

Psychiatric symptoms
--------------------

Patients completed a depression screening (either the Patient Health Questionnaire-9 (PHQ-9) or Geriatric Depression scale-30 (GDS-30). Patients with PHQ-9 score ≥10 or GDS score ≥20 were categorized as having moderate to severe depressive symptoms. All patients met criterion A of post-traumatic stress disorder (PTSD) from the *Diagnostic and Statistical Manual of Mental Disorders* (DSM-5)[@b22-ijgm-12-125]: exposure to actual or threatened death, serious injury, or sexual violence by direct exposure to threatened death from their ICU stay (ie, critical illness requiring mechanical ventilation for ≥24 hours) and/or delirium, a neuropsychiatric morbidity with mortality rate over twice that of critically ill patients without delirium.[@b21-ijgm-12-125] In addition, all patients reported whether they had specific trauma- and stressor-related symptoms which correlated with the DSM-5 criteria for PTSD.[@b22-ijgm-12-125] These included criterion B: presence of one (or more) intrusion symptoms associated with the traumatic event(s), beginning after the traumatic event(s) occurred (nightmares? flashbacks or stressful memories of your ICU stay?); criterion C: persistent avoidance of stimuli associated with the traumatic event(s), beginning after the traumatic event(s) occurred (fear of places and situations which remind me of the ICU); and criterion E: marked alterations in arousal and reactivity associated with the traumatic event(s), beginning or worsening after the traumatic event(s) occurred (jumpiness, I am easily frightened by sudden sounds or sudden movements).[@b22-ijgm-12-125]

Statistical analyses
--------------------

Demographic and clinical characteristics were compared using Fisher's exact tests for categorical variables and Wilcoxon Rank-Sum tests for continuous outcomes ([Table 1](#t1-ijgm-12-125){ref-type="table"}). A multivariate logistic regression model was performed to examine whether there was an association between psychiatric symptoms and the reported sleep disturbances. Demographic and clinical variables with *P*\<0.1 in a univariate analysis ([Table 1](#t1-ijgm-12-125){ref-type="table"}) and associations with sleep outcomes based on prior research or clinical judgment were included as covariates in a multivariate logistic regression model ([Table 2](#t2-ijgm-12-125){ref-type="table"}).[@b23-ijgm-12-125] *P*\<0.05 was considered statistically significant. All analyses were performed using SAS v 9.4.

Results
=======

The study population of 112 ICU survivors with a mean age of 52.2 years was critically ill; 84.8% (N=95) had respiratory failure; and 77.7% (N=87) had delirium. Over one-third (34.8%, N=39) had current depressive symptoms, and almost half had at least one current trauma-related symptom (43.8%, N=49). More than half (52.7%, N=59) reported sleep disturbances after their ICU stay.

Patients with sleep disturbances were younger, more likely to have current depressive symptoms, and more likely to have current trauma-related symptoms. Surprisingly, patients with alcohol use disorder and respiratory failure were less likely to have sleep disturbances. There were no differences in antidepressant or benzodiazepine/nonbenzodiazepine hypnotic use between patients with and without sleep disturbances. There were no differences in pre-existing psychiatric or sleep disorders between patients with and without sleep disturbances ([Table 1](#t1-ijgm-12-125){ref-type="table"}). In a logistic regression analysis, the combination of trauma-related and depression symptoms (OR 16.66, 95% CI 2.89--96.00) and trauma-related symptoms alone (OR 4.59, 95% CI 1.11--18.88) were most closely associated with a higher likelihood of sleep disturbances. When trauma-related symptoms were excluded, depression symptoms were no longer associated with sleep disturbances (OR 1.35, 95% CI 0.23--7.83) ([Table 2](#t2-ijgm-12-125){ref-type="table"}).

Discussion
==========

The 2018 clinical practice guidelines for pain, agitation/ sedation, delirium, immobility, and sleep recognize the importance of addressing evidence gaps in sleep of critically ill patients.[@b24-ijgm-12-125] Our study suggests that trauma-related and depression symptoms are significant risk factors for sleep disturbances. It also suggests older patients are less prone to report subjective sleep disturbances, similar to prior studies suggesting older patients better tolerate chronic sleep deprivation.[@b25-ijgm-12-125],[@b26-ijgm-12-125] More than half of our post-ICU population reported sleep disturbances, consistent with previous studies.[@b4-ijgm-12-125] It was a diverse group with over 40% of the patients being African-American. They survived significant critical illness as the majority had respiratory failure requiring mechanical ventilation. Only 7.1% of patients had sleep disorders and 13.4% had psychiatric disorders prior to ICU admission. There were no differences in post-ICU sleep disturbances in these groups ([Table 1](#t1-ijgm-12-125){ref-type="table"}).

Our study is consistent with prior studies showing a strong correlation between psychiatric symptoms and post-ICU sleep disturbances. Mental health symptoms were noted to be independently associated with poorer sleep quality in ICU survivors 6 months after discharge by McKinley et al.[@b12-ijgm-12-125] About 1 in 5 ICU survivors suffer from clinically significant PTSD symptoms and over one in four suffer from clinically significant depression.[@b27-ijgm-12-125],[@b28-ijgm-12-125] Our findings that post-ICU trauma-related symptoms alone and both trauma-related and depression symptoms were associated with post-ICU sleep disturbances suggest that psychiatric symptoms are a significant risk factor for post-ICU sleep disturbances. Given the lack of correlation between pre-ICU psychiatric diagnoses and post-ICU sleep disturbances in the CCRC cohort, this study suggests that ICU hospitalization may play a key role in the evolution of post-ICU psychiatric symptoms, particularly those related to trauma, and eventually, post-ICU sleep disturbances.

ICU survivors with sleep disturbances suffer from impaired Health-Related Quality of Life (HRQoL)[@b4-ijgm-12-125],[@b5-ijgm-12-125] and prior studies have tied psychological distress specifically to lower quality of life in these patients.[@b10-ijgm-12-125],[@b29-ijgm-12-125] The significant contribution of psychiatric morbidity to sleep disturbances and HRQoL in ICU survivors should be considered for targeted interventions while developing sleep-improvement programs. Our data contribute to the growing and needed epidemiologic basis of post-ICU morbidity and provide novel insights into psychiatric co-morbidities and sleep disturbances.

The finding of low sleep disturbances in patients with higher rates of respiratory failure and alcohol use disorder in this study is surprising, which differs from earlier findings.[@b4-ijgm-12-125],[@b30-ijgm-12-125] While the number of patients with alcohol use disorder in each group was low, many of the patients enrolled had respiratory failure. Our diverse, urban, single-center study may not be representative of a typical medical ICU regarding psychiatric conditions, alcohol use disorder, and other demographic and comorbid criteria. Therefore, these findings will need to be examined in more detail in future studies.

Limitations
===========

This study had several limitations. First, the sample size of ICU survivors is fairly small and from a single site. Second, there were no objective data available to confirm the patients' subjective sleep complaints (eg, polysomnogram, actigraphy) and the subjective questionnaire is not a validated one. Third, their exposure to non-pharmacologic treatments, eg, depression-focused psychotherapies, was unknown. Fourth, the possibility of selection bias was introduced without control of the variables measured in this study for the 3 months prior to their clinic visit. Fifth, although the questionnaire probed for trauma and stressor-related symptoms, they did not comprehensively cover all the PTSD symptoms.

Conclusion
==========

ICU survivors who had active psychiatric symptoms were more likely to have subjective sleep disturbances. Future work will need to confirm these findings in larger, multisite longitudinal studies with validated sleep questionnaires in addition to objective measurements such as polysomnography or actigraphy. They will also need to better characterize psychiatric symptoms using DSM-5 criteria for specific diagnoses, and clarify further the relationships between sleep, psychotropic treatment, and psychotherapy in the ICU survivor population.
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###### 

Demographics and clinical characteristics of 112 ICU survivors grouped by subjective sleep disturbances at the initial CCRC visit

  Characteristics                                                                                               No sleep disturbances (N=53)   Sleep disturbances (N=59)   *P*-value
  ------------------------------------------------------------------------------------------------------------- ------------------------------ --------------------------- -----------
  **Demographics**                                                                                                                                                         
   Age (years)                                                                                                  56.8 (10.9)                    48.0 (14.1)                 0.001
   Female, %                                                                                                    45.3 (24)                      54.2 (32)                   0.449
   African-American, %                                                                                          43.4 (23)                      42.4 (25)                   1.000
   Education (years)                                                                                            11.9 (2.4)                     11.6 (3.2)                  0.513
  **Comorbidities**                                                                                                                                                        
   Alcohol use disorder (current or previous), %                                                                39.6 (19)                      24.1 (14)                   0.097
   Tobacco use disorder (current or previous), %                                                                81.1 (43)                      71.2 (42)                   0.271
   CNS disorder, %                                                                                              45.3 (24)                      57.6 (34)                   0.256
   Cardiac disease, %                                                                                           41.5 (22)                      28.8 (17)                   0.171
   Hypertension, %                                                                                              77.4 (41)                      59.3 (35)                   0.046
   Diabetes, %                                                                                                  30.2 (16)                      32.2 (19)                   0.841
   COPD, %                                                                                                      58.5 (31)                      42.4 (25)                   0.130
   Cancer, %                                                                                                    15.1 (8)                       17.0 (10)                   1.000
   Psychiatric disorder, %                                                                                      11.3 (6)                       15.2 (9)                    0.590
   Sleep disorder, %                                                                                            7.6 (4)                        6.8 (4)                     1.000
  **Hospital characteristics[b](#tfn3-ijgm-12-125){ref-type="table-fn"}**                                                                                                  
   Length of hospitalization (days)                                                                             17.0 (11.3)                    21.3 (23.3)                 0.987
   Length of ICU (days)                                                                                         12.2 (9.8)                     13.1 (18.3)                 0.271
   Delirium during entire hospitalization, %                                                                    84.9 (45)                      71.2 (42)                   0.112
   Respiratory failure, %                                                                                       96.2 (51)                      74.6 (44)                   0.001
  **Initial CCRC visit information**                                                                                                                                       
   Time between initial visit in CCRC and discharge from the hospital (days)                                    116.8 (87.2)                   93.8 (62.3)                 0.186
   MMSE (0--30 points)                                                                                          26.2 (4.2)                     25.5 (4.7)                  0.588
   Antidepressant prescription at initial CCRC visit, %                                                         24.5 (13)                      42.4 (25)                   0.071
   Benzodiazepine or nonbenzodiazepine hypnotic prescription at initial CCRC visit, %                           13.2 (7)                       5.1 (3)                     0.187
  **Global trauma-related and depression symptoms**                                                                                                                        0.009
   Trauma-related and depression symptoms                                                                       5.7 (3)                        39.0 (23)                   
   Trauma-related symptoms, no depression symptoms                                                              15.1 (8)                       25.4 (15)                   
   Depression symptoms, no trauma-related symptoms                                                              13.2 (7)                       10.2 (6)                    
   No trauma-related or depression symptoms, history of depression[b](#tfn3-ijgm-12-125){ref-type="table-fn"}   26.4 (14)                      10.2 (6)                    
   No trauma-related or depression symptoms, no history of depression                                           39.6 (21)                      15.2 (9)                    

**Notes:** Continuous variables were expressed as average (SD). Categorical variables were expressed as % (N). *P*-values are from comparisons between those with no changes in sleep and changes in sleep groups. Patients who were on any dose of a tricyclic antidepressant, serotonin reuptake inhibitor, serotonin--norepinephrine reuptake inhibitor, noradrenergic and specific serotonergic antidepressant (eg, mirtazapine), or norepinephrine and dopaminergic reuptake inhibitor (eg, bupropion) were considered to be on an antidepressant. Nonbenzodiazepine hypnotics were defined as drugs with effects similar to benzodiazepines, eg, zolpidem, zopiclone, eszopiclone, and zaleplon. Depression symptoms were defined as patients who indicated moderate to severe depressive symptoms (Geriatric Depression Scale-30 ≥20 or Patient Health Questionnaire-9 ≥10) at the initial CCRC visit prior to treatment in the CCRC. Trauma-related symptoms were defined as patients who endorsed having at least one of the following: nightmares, flashback or stressful memory of ICU stay, jumpiness (easily frightened or startled by sudden movements), or fear or place of situations that remind people of their ICU stay.

Hospital stay with sentinel ICU stay resulting in CCRC referral.

History of depression was defined as a diagnosis of depression based on informant report or chart diagnosis of depression. Fisher's exact tests were used to compare categorical outcomes for the two groups. Wilcoxon Rank-Sum tests were used to compare continuous outcomes for the two groups. Psychiatric and sleep disorders were defined as any relevant ICD-9 or ICD-10 diagnoses by chart review within the 365 days prior to ICU admission.

**Abbreviations:** CCRC, Critical Care Recovery Center; CNS, central nervous disease; ICU, intensive care unit; MMSE, Mini-Mental State Examination.
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Psychiatric symptoms and sleep disturbances

  Demographic and clinical characteristics                             Sleep disturbances OR (95% CI)   Sleep disturbances *P*-value
  -------------------------------------------------------------------- -------------------------------- ------------------------------
  Age, years                                                           0.97 (0.93--1.02)                0.222
  Hypertension                                                         0.96 (0.29--3.21)                0.952
  Respiratory failure                                                  0.15 (0.03--0.85)                0.031
  Antidepressant prescription at initial visit                         1.10 (0.33--3.65)                0.881
  Alcohol use disorder (current or previous)                           0.29 (0.10--0.88)                0.028
  **Global trauma-related and depression symptoms**                                                     
  Trauma-related and depression symptoms                               16.66 (2.89--96.00)              0.002
  Trauma-related symptoms, no depression symptoms                      4.59 (1.11--18.88)               0.035
  Depression symptoms, no trauma-related symptoms                      1.35 (0.23--7.83)                0.738
  No trauma-related or depression symptoms, history of depression      0.95 (0.23--3.89)                0.946
  No trauma-related or depression symptoms, no history of depression   1.00 (reference)                 

**Notes:** OR and 95% CI were calculated using logistic regression models. Models controlled for covariates *P*\<0.1.
